Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GlaxoSmithKline (5 OTC drugs)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of 5 Over The Counter drugs of GlaxoSmithKline headquartered in England, United Kingdom. The portfolio of drugs consists of five brands well recommended by physicians.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Products
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Brentford TW8
  • England

GlaxoSmithKline (5 OTC drugs) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GlaxoSmithKline (5 OTC drugs)‘s full profile, request access.

Request full access to PitchBook

GlaxoSmithKline (5 OTC drugs) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GlaxoSmithKline (5 OTC drugs)‘s full profile, request access.

Request full access to PitchBook